Login / Signup

Identification of Circular RNAs as Biomarker Candidates in Lung Cancer Treatment.

Busra ApaydinUfuk MertMilad AsadiCan MuftuogluAyşe Caner
Published in: Asian Pacific journal of cancer prevention : APJCP (2024)
As a result, while carboplatin, pemetrexed, and combined drug applications changed the expression levels of some circRNAs in lung cancer cells, some circRNAs were expressed only after treatment. In treatment follow-up and management, hsa_circ_0001320 has been identified as potential biomarker candidate.
Keyphrases
  • small cell lung cancer
  • poor prognosis
  • randomized controlled trial
  • emergency department
  • combination therapy
  • phase ii study
  • rectal cancer